Jornadas Paraguay 2015

SOLACI Regional Sessions Asunción (Paraguay)
September 17-18, 2015 // Program


abreu_concurso_cardiologos

Dr. Rodrigo Abreu won the prize  “to the better case” in the “Contest of Cases for Young Cardiologysts” that took place during the Paraguay 2015 Sessions, which were sponsored by ABBOTT Vascular.

The prize consists in the economic coverage to asist to the SOLACI Congress 2016, in Rio de Janeiro, Brazil, including air ticket, acommodation and registration. ¡Congratulations!

More articles by this author

Peru Sessions 2023

Held on November 16 and 17, 2023 in the Good Hope Clinic Auditorium, Lima, Peru! The XLVII SOLACI 2023 Regional Sessions (16th Andean Region) was...

Colombia Sessions 2022

XLV SOLACI Regional Sessions– 15° Andean Region. October 6, 7 & 8, 2022 The XLV SOLACI Regional Sessions (15th Andean Region) were held on October 6,...

Paraguay 2022 Sessions

44th SOLACI Regional Sessions - 15th Southern Cone Regional Meeting June 30th - July 1st The 44th SOLACI Regional Sessions (15th Region Southern Cone) took place...

Mexico Sessions 2021

The XLIV SOLACI Mexico Sessions 2021 were held on December 9, 2021 within the framework of the SOCIME 2021 Congress. The activity consisted of a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....